Kala Bio KALA Income Statement (2016-2026)

NASDAQ KALA
$0.84 -0.06 (-6.67%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter)
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.05M0.05M0.05M0.06M0.06M0.06M0.09M0.08M0.13M0.13M0.15M0.16M11.87M
Revenue & cost
Revenue (Quarter)
3.05M3.07M1.86M1.37M2.10M0.42M
Gross Profit (Quarter)
2.04M2.16M0.44M0.60M0.33M0.41M
Operating items
Research & Development (Quarter)
3.09M2.88M2.41M4.47M4.47M5.39M3.32M4.04M4.28M5.55M4.72M6.35M5.32M5.17M5.26M6.05M6.23M6.13M0.37M0.06M
Selling, General & Administrative (Quarter)
27.99M25.35M24.03M26.98M22.67M9.55M5.83M6.03M4.96M4.95M4.62M5.42M4.32M4.40M4.20M4.59M4.64M4.53M9.86M1.74M
Other Operating Expenses (Quarter)
-7.45M-2.06M-0.75M-2.03M-2.14M46.99M1.62M0.36M-1.74M0.28M0.16M-0.03M0.42M0.02M0.15M-3.42M
Operating Expenses (Quarter)
32.10M29.14M48.67M32.29M28.07M14.99M10.25M11.68M9.60M8.76M9.62M11.93M9.61M9.99M9.46M10.67M11.03M7.24M10.22M1.80M
Operating Income (Quarter)
-29.05M-26.07M-46.81M-30.91M-25.97M-14.57M-10.25M-11.68M-9.60M-8.76M-9.62M-11.93M-9.61M-9.99M-9.46M-10.67M-11.03M-7.24M-10.22M-1.80M
EBIT (Quarter)
-29.05M-26.07M-46.81M-30.91M-25.97M-14.57M-10.25M-11.68M-9.60M-8.76M-9.62M-11.93M-9.61M-9.99M-9.46M-10.67M-11.03M-7.24M-10.22M-1.80M
Non-operating items
Interest & Investment Income (Quarter)
0.03M0.02M0.01M0.01M0.07M0.23M0.35M0.68M0.72M0.71M0.61M0.50M0.50M0.57M0.48M0.46M0.41M0.27M0.07M
Other Non Operating Income (Quarter)
-5.39M-2.58M-3.03M-1.97M-0.12M-2.16M-0.01M1.07M0.98M1.95M2.20M2.35M0.55M-0.11M5.91M0.11M
Non Operating Income (Quarter)
-2.06M-0.75M-2.03M-2.14M43.64M-2.59M-2.77M-0.81M0.06M0.99M0.12M0.03M1.04M1.28M1.72M-0.13M-0.33M10.91M0.18M
Net income details
EBT (Quarter)
-31.23M-28.27M-48.95M-32.94M-28.11M-15.78M-10.17M-12.48M-10.29M-9.51M-10.48M-12.88M-10.56M-10.90M-10.37M-11.30M-11.70M-7.93M-10.80M-1.73M
Profit After Tax (Quarter)
-36.50M-28.13M-47.57M-32.94M-28.11M29.07M-12.84M-14.46M-10.41M-8.70M-8.63M-11.81M-9.58M-8.95M-8.18M-8.95M-11.15M-7.56M0.69M-1.62M
Income from Continuing Operations (Quarter)
-31.23M-28.27M-48.95M-32.94M-28.11M-15.78M-10.17M-12.48M-10.29M-9.51M-10.48M-12.88M-10.56M-10.90M-10.37M-11.30M-11.70M-7.93M-10.80M-1.73M
Consolidated Net Income (Quarter)
-31.23M-28.27M-48.95M-32.94M-28.11M-15.78M-10.17M-12.48M-10.29M-9.51M-10.48M-12.88M-10.56M-10.90M-10.37M-11.30M-11.70M-7.93M-10.80M-1.73M
Income towards Parent Company (Quarter)
-31.23M-28.27M-48.95M-32.94M-28.11M-15.78M-10.17M-12.48M-10.29M-9.51M-10.48M-12.88M-10.56M-10.90M-10.37M-11.30M-11.70M-7.93M-10.80M-1.73M
Net Income towards Common Stockholders (Quarter)
-36.50M-28.13M-47.57M-32.94M-28.11M29.07M-12.84M-14.46M-10.41M-8.70M-8.63M-11.81M-9.58M-8.95M-8.18M-8.95M-11.15M-7.56M0.69M-1.73M
Additional items
EPS (Basic) (Quarter)
-0.00M-0.00M-0.00M-0.00M-953.85969.75-422.30-349.29-218.05-170.65-177.36-209.85-158.06-96.70-107.68-70.49-85.64-53.704.21-0.15
EPS (Diluted) (Quarter)
-0.00M-0.00M-0.00M-0.00M-953.85962.43-422.30-349.29-218.05-170.65-177.36-209.85-158.06-96.70-107.68-70.49-85.64-53.704.21-0.15
Shares Outstanding (Quarter)
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.04M0.05M0.05M0.05M0.06M0.06M0.09M0.08M0.13M0.13M0.14M0.16M11.87M
Shares Outstanding (Diluted) (Quarter)
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.04M0.05M0.05M0.05M0.06M0.06M0.09M0.08M0.13M0.13M0.14M0.16M11.87M
EBITDA (Quarter)
-29.05M-26.07M-46.81M-30.91M-25.97M-14.57M-10.25M-11.68M-9.60M-8.76M-9.62M-11.93M-9.61M-9.99M-9.46M-10.67M-11.03M-7.24M-10.22M-1.80M
Interest Expenses (Quarter)
2.22M2.22M2.15M2.04M2.21M1.45M0.27M1.47M1.41M1.46M1.47M1.46M1.46M1.48M1.39M1.09M1.08M0.96M0.57M